Lancet hydroxychloroquine Covid19 study was a lie

Posted by .(JavaScript must be enabled to view this email address)
Friday, June 05, 2020 4:20 pm Email this article

A study published in The Lancet claimed that chloroquine and hydroxychloroquine increases the risk of death in COVID-19 patients.

But the data used in this study appear to have been “completely fabricated”, “in what is possibly a criminal conspiracy” according to Peter Ellis, a professional statistician and data scientist.

The Lancet paper was retracted on June 5, 2020, and the world Health Organization resumed trials of hydroxychloroquine for treating Covid-19, which had been stopped due to this “study”.

 

People on Twitter under the hashtag #lancetgate did a great job revealing problems with Surgisphere, the company behind this study, problems with Sapan Desai, the founder of Surgisphere, problems with employees of Surgisphere, and how Madeep R. Mehra, MD, the lead author on this paper, had financial ties to Gilead Sciences, the makers of remdesivir, a competing drug.

Articles on the same subject can be found here:

• Coronavirus COVID-19

• Hydroxychloroquine